Related Experiment Video
Updated: Dec 25, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and
Rocco Sciarrillo1, Anna Wojtuszkiewicz2, Irsan E Kooi3
1Amsterdam UMC, Vrije Universiteit Amsterdam, Departments of Pediatric Oncology, Hematology and Medical Oncology, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
Abstract:
Glucocorticoid (GC) resistance is a crucial determinant of inferior response to chemotherapy in pediatric acute lymphoblastic leukemia (ALL); however, molecular mechanisms underlying this phenomenon are poorly understood. Deregulated splicing is a common feature of many cancers, which impacts drug response and constitutes an attractive therapeutic target. Therefore, the aim of the current study was to characterize global splicing profiles associated with GC resistance and determine whether splicing modulation could serve as a novel therapeutic option for GC-resistant patients. To this end, 38 primary ALL samples were profiled using RNA-seq-based differential splicing analysis. The impact of splicing modulators was investigated in GC-resistant leukemia cell lines and primary leukemic specimens. Our findings revealed, for the first time, markedly distinct splicing landscapes in ALL samples of B-cell precursor (BCP)-ALL and T-ALL lineages. Differential splicing events associated with GC resistance were involved in RNA processing, a direct response to GCs, survival signaling, apoptosis, cell cycle regulation and energy metabolism. Furthermore, our analyses showed that GC-resistant ALL cell lines and primary samples are sensitive to splicing modulation, alone and in combination with GC. Together, these findings suggest that aberrant splicing is associated with GC resistance and splicing modulators deserve further interest as a novel treatment option for GC-resistant patients.
Insights
Glucocorticoid resistance in pediatric acute lymphoblastic leukemia (ALL) is linked to altered gene splicing. Targeting these splicing changes may offer a new treatment strategy for resistant leukemia.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glucocorticoid (GC) resistance significantly impairs chemotherapy response in pediatric acute lymphoblastic leukemia (ALL).
- The molecular basis of GC resistance in ALL remains largely unknown.
- Deregulated gene splicing is implicated in various cancers and affects drug sensitivity.
Purpose of the Study:
- To investigate global splicing profiles in relation to GC resistance in ALL.
- To explore the potential of splicing modulation as a therapeutic approach for GC-resistant ALL.
Main Methods:
- RNA-sequencing (RNA-seq) was employed for differential splicing analysis on 38 primary ALL samples.
- Splicing modulators were tested in GC-resistant ALL cell lines and primary specimens.
Main Results:
- Distinct splicing landscapes were identified between B-cell precursor (BCP)-ALL and T-ALL subtypes.
- GC resistance-associated splicing alterations were observed in pathways including RNA processing, GC response, cell survival, apoptosis, cell cycle, and metabolism.
- GC-resistant ALL cells demonstrated sensitivity to splicing modulators, both independently and in combination with GCs.
Conclusions:
- Aberrant splicing is significantly associated with GC resistance in pediatric ALL.
- Splicing modulators represent a promising therapeutic avenue for treating GC-resistant ALL patients.
More Related Videos
12:58Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Leaky Scanning